Allogene Therapeutics ALLO Business Segments — Other operating expenses

Similar metrics at other companies

SCORReportable Segment — Other operating expenses

$1.42M+15.2%

SHAKReportable Segment — Other operating expenses

$63.12M+24.3%

MQReportable Segment — Other operating expenses

$3.57M-9.6%

IIIVReportable Segment — Other operating expenses

$5.42M+17.2%

COOKReportable Segment — Other operating expenses

$40.93M-24.6%

FGReportable Segment — Other operating expenses

$41M-2.4%

FAQ

What is Allogene Therapeutics's business segments — other operating expenses?

Allogene Therapeutics (ALLO) reported business segments — other operating expenses of $11.19M in Q1 2026.

How has Allogene Therapeutics's business segments — other operating expenses changed year-over-year?

Allogene Therapeutics's business segments — other operating expenses decreased by 29.2% year-over-year, from $15.81M to $11.19M.

What is the long-term trend for Allogene Therapeutics's business segments — other operating expenses?

Over 2 years (2023 to 2025), Allogene Therapeutics's business segments — other operating expenses has grown at a -25.0% compound annual growth rate (CAGR), from $95.37M to $53.59M.

What does business segments — other operating expenses mean?

This metric aggregates miscellaneous operating costs not captured in specific functional categories like payroll or R&D. It includes general administrative overhead and other incidental expenses necessary for day-to-day business continuity. Monitoring this helps identify potential inefficiencies or unexpected administrative burdens.